Faruqi & Faruqi, LLP is Investigating Alnylam Pharmaceuticals, Inc. (ALNY) on Behalf of its Shareholders

Jul 17, 2015, 10:48 ET from Faruqi & Faruqi, LLP

NEW YORK, July 17, 2015 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at Alnylam Pharmaceuticals, Inc. ("Alnylam" or the "Company") (NASDAQ: ALNY).

The investigation focuses on whether the Company and its officers breached their fiduciary duties with respect to the Alnylam's corporate governance controls.

Request more information now by clicking herewww.faruqilaw.com/ALNY. There is no cost or obligation to you.

Take Action
If you currently own Alnylam stock and have continuously owned Alnylam stock and would like to discuss your legal rights, please visit www.faruqilaw.com/ALNY. You can also contact us by calling Nadeem Faruqi toll free at (212) 983-9330 or by sending an e-mail to nfaruqi@faruqilaw. Faruqi & Faruqi, LLP also encourages anyone with information regarding Alnylam's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.

369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn:  Nadeem Faruqi
Telephone: (212) 983-9330

Logo - http://photos.prnewswire.com/prnh/20120119/MM38856LOGO


SOURCE Faruqi & Faruqi, LLP